Loading…
Loading…
Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
taxon 1773Also known as: Bacillus tuberculosis, Bacterium tuberculosis, Mycobacterium tuberculosis (Zopf 1883) Lehmann and Neumann 1896 (Approved Lists 1980), Mycobacterium tuberculosis typus humanus, Mycobacterium tuberculosis var. hominis
Not yet assessed
Occurrence records: Recorded mostly outside Africa. 486 of 8,564 GBIF records (6%) are from Africa (checked 10/9/2026). A hint from GBIF and the genomes on this Hub, not an assessment: GBIF includes zoo and travel records.
Species that share this one's nearest groups in NCBI Taxonomy. This is how they're classified, not a phylogeny. See it in the species tree.
Origin: hub
61 downloads
First synced: 10/11/2026 · Last updated: 10/12/2026
Source: NCBI GCF_001835515.1 · View at source ↗
Download annotation (GFF3) · Download CDS (FASTA) · Download proteins (FASTA)
Collection: South Africa
Sequencing: Illumina MiSeq · ABySS v. 1.9.0 · 70x coverage
Released: 2016-10-24 · Submitted by: USDA Animal Plant Health Inspection Service-National Veterinary Services Laboratories
publiccc0AFDSI-SEQ-5883 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: ZA · PIC: unknown · MAT: unknown
GoaT: no record for this species (not eukaryotic, or not yet sequenced)
Publicly accessible — no request needed.
Origin: hub
59 downloads
First synced: 10/11/2026 · Last updated: 10/12/2026
Source: NCBI GCF_001835505.1 · View at source ↗
Download annotation (GFF3) · Download CDS (FASTA) · Download proteins (FASTA)
Collection: South Africa
Sequencing: Illumina MiSeq · ABySS v. 1.9.0 · 84x coverage
Released: 2016-10-24 · Submitted by: USDA Animal Plant Health Inspection Service-National Veterinary Services Laboratories
publiccc0AFDSI-SEQ-5884 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: ZA · PIC: unknown · MAT: unknown
GoaT: no record for this species (not eukaryotic, or not yet sequenced)
Publicly accessible — no request needed.
Origin: hub
58 downloads
First synced: 10/11/2026 · Last updated: 10/12/2026
Source: NCBI GCF_001835535.1 · View at source ↗
Download annotation (GFF3) · Download CDS (FASTA) · Download proteins (FASTA)
Collection: South Africa
Sequencing: Illumina MiSeq · ABySS v. 1.9.0 · 93x coverage
Released: 2016-10-24 · Submitted by: USDA Animal Plant Health Inspection Service-National Veterinary Services Laboratories
publiccc0AFDSI-SEQ-5885 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: ZA · PIC: unknown · MAT: unknown
GoaT: no record for this species (not eukaryotic, or not yet sequenced)
Publicly accessible — no request needed.
Origin: hub
0 downloads
First synced: 11/8/2026 · Last updated: 11/8/2026
Source: NCBI QS319150.1 · View at source ↗
Released: 2026-05-16
publiccc0AFDSI-SEQ-6543 Country of origin not recorded: see how benefit-sharing works →Publicly accessible — no request needed.
No AlphaFold DB proteome found for this species.
PRIDE — project-level reference (metadata only; no per-protein identifications are available via PRIDE's public API)
The Mycobacterium tuberculosis ESX-1 secretion system controls antigen presentation on MHC-I in human macrophages (PXD084949) ↗AFDSI-PROJREF-753
Comparative quantitative proteomic analysis of Mycobacterium tuberculosis H37Rv cultured under metal-limited (Chelated Sauton's medium) and metal-rich (7H9) conditions (PXD081785) ↗AFDSI-PROJREF-754
Proteomic analysis of HoxB8-derived macrophages in which the Slc31a1 or Atp7a genes were inactivated using CRISPR/Cas9 (PXD076718) ↗AFDSI-PROJREF-756
Beyond Inhibition - Sub-lethal Rifampicin-induced molecular adaptations confer phenotypic drug tolerance in Mycobacteria (PXD075873) ↗AFDSI-PROJREF-757
Ubiquitylation by the GID/CTLH complex regulates the metabolic and innate immune response of macrophages to infection by Mycobacterium tuberculosis (PXD075792) ↗AFDSI-PROJREF-758
Mapping ISG15 conjugation sites in THP1 cells during infection with Mycobacterium tuberculosis (PXD075338) ↗AFDSI-PROJREF-759
ISG15 regulates the proteome of lipid droplets during Mycobacterium tuberculosis infection in macrophage (PXD075277) ↗AFDSI-PROJREF-760
Alpibectir–Ethionamide combination (AlpE) for the treatment of tuberculosis (PXD075165) ↗AFDSI-PROJREF-761
dia-PASEF Enables Rapid Profiling of the Human Secretome for Deeper Insights into Cellular Dynamics and Inflammatory Mechanisms (PXD074830) ↗AFDSI-PROJREF-762
ChEMBL rows are compounds active against a protein target from this organism — not confirmed as compounds the species itself produces, unlike ANPDB's.
ChEMBL: CHEMBL216547 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-2104
ChEMBL: CHEMBL217926 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10660.0 nMAFDSI-METABOLOMICS-2103
ChEMBL: CHEMBL216781 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 75000.0 nMAFDSI-METABOLOMICS-2110
ChEMBL: CHEMBL265016 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-2112
ChEMBL: CHEMBL217524 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 14830.0 nMAFDSI-METABOLOMICS-2113
ChEMBL: CHEMBL384149 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 1600.0 nMAFDSI-METABOLOMICS-2115
ChEMBL: CHEMBL268773 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; ActivityAFDSI-METABOLOMICS-2116
ChEMBL: CHEMBL231743 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; ActivityAFDSI-METABOLOMICS-2117
ChEMBL: CHEMBL409409 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Activity
MetaboLights: Mycobacterium tuberculosis VadK required for regulation of the methylcitrate cycle and virulence (View at source ↗)AFDSI-METABPROF-272
MetaboLights: Lysine acetyltransferase Rv0998 coordinates transcriptional and metabolic adaptation of Mycobacterium tuberculosis to acidic pH (View at source ↗)AFDSI-METABPROF-268
MetaboLights: Metabolomics profiling reveals changes in peptidoglycan and redox metabolism between ancient and modern Mycobacterium tuberculosis (View at source ↗)AFDSI-METABPROF-269
MetaboLights: Comparative label-free lipidomic analysis of Mycobacterium tuberculosis during dormancy and reactivation (View at source ↗)AFDSI-METABPROF-270
MetaboLights: Multiple acyl-coA dehydrogenase deficiency kills Mycobacterium tuberculosis in vitro and during infection (View at source ↗)AFDSI-METABPROF-271
BioImage Archive: Protective versus Deleterious Roles of Pyroptosis in Mycobacterium avium and Mycobacterium marinum Infections (View on source archive ↗)AFDSI-CELL-4081
BioImage Archive: AFB-Dx: A Digital Pathology Dataset for Tuberculosis Detection and Analysis (View on source archive ↗)AFDSI-CELL-4084
BioImage Archive: Protective versus Deleterious Roles of Pyroptosis in Mycobacterium avium and Mycobacterium marinum Infections (View on source archive ↗)AFDSI-CELL-4082
BioImage Archive: CD4-mediated immunity shapes neutrophil-driven tuberculous pathology (View on source archive ↗)AFDSI-CELL-4087
BioImage Archive: CD4-mediated immunity shapes neutrophil-driven tuberculous pathology (View on source archive ↗)AFDSI-CELL-4088
BioImage Archive: Deep learning extracts MoA-specific signatures from high-throughput images of chemically and genetically perturbed Corynebacteria (View on source archive ↗)AFDSI-CELL-4090
BioImage Archive: Deep learning extracts MoA-specific signatures from high-throughput images of chemically and genetically perturbed Corynebacteria (View on source archive ↗)AFDSI-CELL-4089
BioImage Archive: Simple optical nanomotion method for single-bacterium viability and antibiotic response testing (View on source archive ↗)AFDSI-CELL-4091
BioImage Archive: Simple optical nanomotion method for single-bacterium viability and antibiotic response testing (View on source archive ↗)AFDSI-CELL-4092
BioImage Archive: AFB-Dx: A Digital Pathology Dataset for Tuberculosis Detection and Analysis (View on source archive ↗)AFDSI-CELL-4083
485 real GBIF-recorded occurrences across Africa — see this species on GBIF ↗.
This reflects real occurrence records submitted to GBIF, not a comprehensive range map — sampling effort varies significantly by country and region, so an absence here doesn't mean the species isn't present.
Genomes are often recorded at strain level. These entries belong to this species.
…and 25 more.
A node's own derived bioinformatics-analysis output (e.g. an SSR/microsatellite discovery archive) run against this species' own genome data — see the Derived Analysis page for the full catalog.
MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-5885
File: GCF_001835535.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P patched)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-18478MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-5883
File: GCF_001835515.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P patched)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-18477ChEMBL: RIFAMYCIN S (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10.0 nMAFDSI-METABOLOMICS-2120
ChEMBL: CHEMBL1911286 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 21.0 nMAFDSI-METABOLOMICS-2122
ChEMBL: CHEMBL1911287 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 4400.0 nMAFDSI-METABOLOMICS-2124
ChEMBL: CHEMBL213720 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-2105
ChEMBL: CHEMBL217274 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-2106
ChEMBL: CHEMBL217773 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-2107
ChEMBL: CHEMBL217273 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-2108
ChEMBL: CHEMBL216781 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 75000.0 nMAFDSI-METABOLOMICS-2109
ChEMBL: CHEMBL265016 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-2111
ChEMBL: CHEMBL217524 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 14830.0 nMAFDSI-METABOLOMICS-2114
ChEMBL: CHEMBL384149 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 1600.0 nMAFDSI-METABOLOMICS-2118
ChEMBL: RIFAMYCIN S (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10.0 nMAFDSI-METABOLOMICS-2121
ChEMBL: CHEMBL1911286 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 21.0 nMAFDSI-METABOLOMICS-2123
ChEMBL: CHEMBL1911287 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 4400.0 nMAFDSI-METABOLOMICS-2125
ChEMBL: CHEMBL1911289 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 503.0 nMAFDSI-METABOLOMICS-2126
ChEMBL: CHEMBL1911295 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 15400.0 nMAFDSI-METABOLOMICS-2127
ChEMBL: CHEMBL1911296 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 15.0 nMAFDSI-METABOLOMICS-2129
ChEMBL: RIFAMPIN S (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 13.0 nMAFDSI-METABOLOMICS-2132
ChEMBL: CHEMBL1911298 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 142.0 nMAFDSI-METABOLOMICS-2133
ChEMBL: CHEMBL1911306 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 139.0 nMAFDSI-METABOLOMICS-2135
ChEMBL: RIFAMPIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10.0 nMAFDSI-METABOLOMICS-2137
ChEMBL: CYCLOSERINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition %AFDSI-METABOLOMICS-2139
ChEMBL: CHEMBL1911289 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 503.0 nMAFDSI-METABOLOMICS-2128
ChEMBL: CHEMBL1911296 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 15.0 nMAFDSI-METABOLOMICS-2130
ChEMBL: RIFAMPIN S (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 13.0 nMAFDSI-METABOLOMICS-2131
ChEMBL: CHEMBL1911298 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 142.0 nMAFDSI-METABOLOMICS-2134
ChEMBL: CHEMBL1911306 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 139.0 nMAFDSI-METABOLOMICS-2136
ChEMBL: RIFAMPIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10.0 nMAFDSI-METABOLOMICS-2138
ChEMBL: CYCLOSERINE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition %AFDSI-METABOLOMICS-2140
MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-5884
File: GCF_001835505.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P patched)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-18476AfroTB — Annotated VCF
File: SRR998851_library1.vcf.gz
Tool version: bcftools 1.16 / SnpEff 4.3t
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-15409AfroTB — Annotated VCF
File: SRR998849_library1.vcf.gz
Tool version: bcftools 1.16 / SnpEff 4.3t
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-15408